Carl Zeiss Posts Durable Growth Against Temporary Margin Contraction; Raising FVE to $76

Carl Zeiss Meditec, a subsidiary of optical conglomerate Zeiss Group, is a major supplier of surgical microscopes, diagnostic equipment, refractive lasers, and cataract equipment and lenses. The company has an especially strong position in microsurgery, where the market is effectively a duopoly between Zeiss and Danaher’s Leica Microsystems. Zeiss has an approximate 50% share of scopes for neurosurgery, spinal, plastic, and dental and a two thirds share in ophthalmic scopes for eye surgery. The company has been making a push to increase recurring revenue sales, which primarily include consumable treatment packs for laser vision correction and technical service on equipment.